Skip to main content
. Author manuscript; available in PMC: 2016 Jul 6.
Published in final edited form as: Histopathology. 2011 Jun;58(7):1037–1047. doi: 10.1111/j.1365-2559.2011.03860.x

Table 4. Differential expression of the biomarkers in relation to pT stage.

Location Biomarker pT2 pT3 SD between patients SD within patients P-value
Epithelium Shh* 8.3 7.7 2.2 1.9 0.159
SMO* 9.4 9 1.3 1.4 0.233
Ptch* 1.4 3.1 2.2 1.8 <0.001
Gli1* 6.5 7.4 2.8 1.6 0.066
ki67** 1.1 5 6.5 3 0.152
VEGF* 7.7 7.3 2.4 2 0.33

Stroma Shh* 1.1 0.9 0.5 0.6 0.059
SMO* 4.3 4 2 1.7 0.453
Ptch* 8.2 7.3 1.2 1.5 <0.001
Gli1* 4.2 3.9 2 1.9 0.53
VEGF* 2.6 2 1.2 1.2 0.003
CD31*** 19 22 7 7 0.012
*

11-point scale system.

**

Percentage of positive cells.

***

CD31-positive vessels per core.

SD: standard deviation; VEGF: vascular endothelial growth factor.